COMPUGROUP MEDICAL SE & CO K (COP.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:COP - DE000A288904 - Common Stock
22.66 EUR
+0.24 (+1.07%)
COP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. There are concerns on the financial health of COP while its profitability can be described as average. COP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- COP had positive earnings in the past year.
- In the past year COP had a positive cash flow from operations.
- COP had positive earnings in each of the past 5 years.
- COP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- COP's Return On Assets of 1.34% is in line compared to the rest of the industry. COP outperforms 50.00% of its industry peers.
- With a Return On Equity value of 4.15%, COP perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- The Return On Invested Capital of COP (3.53%) is worse than 60.00% of its industry peers.
- COP had an Average Return On Invested Capital over the past 3 years of 4.07%. This is below the industry average of 8.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 4.15% | ||
| ROIC | 3.53% |
ROA(3y)2.65%
ROA(5y)3.3%
ROE(3y)7.71%
ROE(5y)9.17%
ROIC(3y)4.07%
ROIC(5y)4.45%
1.3 Margins
- With a Profit Margin value of 2.34%, COP perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- COP's Profit Margin has declined in the last couple of years.
- COP's Operating Margin of 8.13% is in line compared to the rest of the industry. COP outperforms 60.00% of its industry peers.
- In the last couple of years the Operating Margin of COP has declined.
- With a decent Gross Margin value of 83.85%, COP is doing good in the industry, outperforming 70.00% of the companies in the same industry.
- In the last couple of years the Gross Margin of COP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.13% | ||
| PM (TTM) | 2.34% | ||
| GM | 83.85% |
OM growth 3Y-2.61%
OM growth 5Y-10.29%
PM growth 3Y-23.61%
PM growth 5Y-19.42%
GM growth 3Y32.01%
GM growth 5Y16.44%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COP is destroying value.
- Compared to 1 year ago, COP has less shares outstanding
- The number of shares outstanding for COP has been increased compared to 5 years ago.
- Compared to 1 year ago, COP has a worse debt to assets ratio.
2.2 Solvency
- COP has an Altman-Z score of 1.79. This is a bad value and indicates that COP is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of COP (1.79) is comparable to the rest of the industry.
- The Debt to FCF ratio of COP is 9.74, which is on the high side as it means it would take COP, 9.74 years of fcf income to pay off all of its debts.
- COP has a Debt to FCF ratio (9.74) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.22 is on the high side and indicates that COP has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.22, COP is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | 9.74 | ||
| Altman-Z | 1.79 |
ROIC/WACC0.67
WACC5.27%
2.3 Liquidity
- A Current Ratio of 1.12 indicates that COP should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.12, COP is doing worse than 60.00% of the companies in the same industry.
- COP has a Quick Ratio of 1.09. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
- COP's Quick ratio of 1.09 is on the low side compared to the rest of the industry. COP is outperformed by 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
- The earnings per share for COP have decreased strongly by -45.71% in the last year.
- The earnings per share for COP have been decreasing by -13.58% on average. This is quite bad
- Looking at the last year, COP shows a decrease in Revenue. The Revenue has decreased by -2.19% in the last year.
- COP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.12% yearly.
EPS 1Y (TTM)-45.71%
EPS 3Y-20.77%
EPS 5Y-13.58%
EPS Q2Q%-40%
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y4.02%
Revenue growth 5Y9.12%
Sales Q2Q%0.54%
3.2 Future
- Based on estimates for the next years, COP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.19% on average per year.
- COP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.36% yearly.
EPS Next Y1.4%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
EPS Next 5YN/A
Revenue Next Year2.47%
Revenue Next 2Y2.65%
Revenue Next 3Y2.49%
Revenue Next 5Y0.36%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 43.58, which means the current valuation is very expensive for COP.
- COP's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 28.87. COP is valued rather expensively when compared to this.
- Based on the Price/Forward Earnings ratio of 12.88, the valuation of COP can be described as correct.
- Based on the Price/Forward Earnings ratio, COP is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.96, COP is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.58 | ||
| Fwd PE | 12.88 |
4.2 Price Multiples
- 70.00% of the companies in the same industry are more expensive than COP, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of COP indicates a somewhat cheap valuation: COP is cheaper than 80.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.34 | ||
| EV/EBITDA | 9.24 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)31.03
PEG (5Y)N/A
EPS Next 2Y4.91%
EPS Next 3Y9.19%
5. Dividend
5.1 Amount
- COP has a yearly dividend return of 0.22%, which is pretty low.
- COP's Dividend Yield is comparable with the industry average which is at 2.22.
- Compared to an average S&P500 Dividend Yield of 1.82, COP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
5.2 History
- The dividend of COP is nicely growing with an annual growth rate of 14.75%!
Dividend Growth(5Y)14.75%
Div Incr Years2
Div Non Decr Years3
5.3 Sustainability
- 191.63% of the earnings are spent on dividend by COP. This is not a sustainable payout ratio.
- The dividend of COP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP191.63%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
COMPUGROUP MEDICAL SE & CO K / COP.DE FAQ
What is the ChartMill fundamental rating of COMPUGROUP MEDICAL SE & CO K (COP.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to COP.DE.
Can you provide the valuation status for COMPUGROUP MEDICAL SE & CO K?
ChartMill assigns a valuation rating of 3 / 10 to COMPUGROUP MEDICAL SE & CO K (COP.DE). This can be considered as Overvalued.
How profitable is COMPUGROUP MEDICAL SE & CO K (COP.DE) stock?
COMPUGROUP MEDICAL SE & CO K (COP.DE) has a profitability rating of 4 / 10.
What is the earnings growth outlook for COMPUGROUP MEDICAL SE & CO K?
The Earnings per Share (EPS) of COMPUGROUP MEDICAL SE & CO K (COP.DE) is expected to grow by 1.4% in the next year.
Can you provide the dividend sustainability for COP stock?
The dividend rating of COMPUGROUP MEDICAL SE & CO K (COP.DE) is 2 / 10 and the dividend payout ratio is 191.63%.